352 related articles for article (PubMed ID: 17365340)
1. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective.
Tseng CH
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):1-22. PubMed ID: 17365340
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
[TBL] [Abstract][Full Text] [Related]
3. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
4. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
Hsueh YM; Chiou HY; Huang YL; Wu WL; Huang CC; Yang MH; Lue LC; Chen GS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):589-96. PubMed ID: 9264271
[TBL] [Abstract][Full Text] [Related]
5. Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment.
Irvine L; Boyer IJ; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):53-68. PubMed ID: 16496296
[TBL] [Abstract][Full Text] [Related]
6. Trivalent arsenicals are bound to proteins during reductive methylation.
Naranmandura H; Suzuki N; Suzuki KT
Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239
[TBL] [Abstract][Full Text] [Related]
7. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
[TBL] [Abstract][Full Text] [Related]
8. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
Soto-Reyes E; Del Razo LM; Valverde M; Rojas E
Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750
[TBL] [Abstract][Full Text] [Related]
9. Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats.
Cui X; Kobayashi Y; Hayakawa T; Hirano S
Toxicol Sci; 2004 Dec; 82(2):478-87. PubMed ID: 15342953
[TBL] [Abstract][Full Text] [Related]
10. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent urinary phenotype of inorganic arsenic methylation in mice with a focus on trivalent methylated metabolites.
García-Montalvo EA; Valenzuela OL; Sánchez-Peña LC; Albores A; Del Razo LM
Toxicol Mech Methods; 2011 Nov; 21(9):649-55. PubMed ID: 22003923
[TBL] [Abstract][Full Text] [Related]
12. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
13. Distribution of urinary selenium and arsenic among pregnant women exposed to arsenic in drinking water.
Christian WJ; Hopenhayn C; Centeno JA; Todorov T
Environ Res; 2006 Jan; 100(1):115-22. PubMed ID: 16337848
[TBL] [Abstract][Full Text] [Related]
14. The cellular metabolism and systemic toxicity of arsenic.
Thomas DJ; Styblo M; Lin S
Toxicol Appl Pharmacol; 2001 Oct; 176(2):127-44. PubMed ID: 11601889
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
Kitchin KT
Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
[TBL] [Abstract][Full Text] [Related]
16. Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area.
Li X; Li B; Xu Y; Wang Y; Jin Y; Itoh T; Yoshida T; Sun G
Environ Toxicol; 2011 Apr; 26(2):118-23. PubMed ID: 19768748
[TBL] [Abstract][Full Text] [Related]
17. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
Hayakawa T; Kobayashi Y; Cui X; Hirano S
Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
[TBL] [Abstract][Full Text] [Related]
18. Binding of dimethylarsinous acid to cys-13alpha of rat hemoglobin is responsible for the retention of arsenic in rat blood.
Lu M; Wang H; Li XF; Arnold LL; Cohen SM; Le XC
Chem Res Toxicol; 2007 Jan; 20(1):27-37. PubMed ID: 17226924
[TBL] [Abstract][Full Text] [Related]
19. Urinary arsenic species and CKD in a Taiwanese population: a case-control study.
Hsueh YM; Chung CJ; Shiue HS; Chen JB; Chiang SS; Yang MH; Tai CW; Su CT
Am J Kidney Dis; 2009 Nov; 54(5):859-70. PubMed ID: 19682779
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the pathway for arsenic methylation.
Thomas DJ; Waters SB; Styblo M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):319-26. PubMed ID: 15276411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
